HuMAIN trial
Rivus Advances in Obesity-Related Heart Failure with Mid-Stage Success of HU6
Rivus Pharmaceuticals, HU6, obesity-related heart failure, Phase IIa HuMAIN trial, controlled metabolic accelerator, muscle-preserving weight loss
Actionable Insights Powered by AI
Rivus Pharmaceuticals, HU6, obesity-related heart failure, Phase IIa HuMAIN trial, controlled metabolic accelerator, muscle-preserving weight loss